1. Home
  2. NWTG vs XBIO Comparison

NWTG vs XBIO Comparison

Compare NWTG & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newton Golf Company Inc.

NWTG

Newton Golf Company Inc.

HOLD

Current Price

$0.96

Market Cap

7.3M

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$2.86

Market Cap

7.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NWTG
XBIO
Founded
2018
N/A
Country
United States
United States
Employees
N/A
2
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
7.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NWTG
XBIO
Price
$0.96
$2.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.1K
9.8K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$53.21
$2.81
Revenue Next Year
$40.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$1.90
52 Week High
$2.23
$13.93

Technical Indicators

Market Signals
Indicator
NWTG
XBIO
Relative Strength Index (RSI) 36.66 41.51
Support Level $0.82 $2.70
Resistance Level $2.01 $3.12
Average True Range (ATR) 0.10 0.16
MACD -0.01 -0.03
Stochastic Oscillator 18.15 2.95

Price Performance

Historical Comparison
NWTG
XBIO

About NWTG Newton Golf Company Inc.

Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Share on Social Networks: